ERMS: Difference between revisions
CSV import |
CSV import Tag: Reverted |
||
| Line 29: | Line 29: | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 10:12, 17 March 2025
ERMS or Embryonal Rhabdomyosarcoma is a rare type of cancer that primarily affects children. It is a subtype of Rhabdomyosarcoma, which is a cancer of the soft tissues. ERMS typically originates in the muscles but can also develop in other areas of the body.
Overview
ERMS is a type of sarcoma, a category of cancers that develop in the connective tissues of the body. It is the most common type of Rhabdomyosarcoma, accounting for approximately 60% of all cases. ERMS typically affects children under the age of 10, but it can also occur in adolescents and adults.
Symptoms
The symptoms of ERMS can vary depending on the location of the tumor. Common symptoms include a noticeable lump or swelling, pain or discomfort, and difficulty with certain functions such as swallowing or urination. In some cases, ERMS may not cause any symptoms until the disease has advanced.
Diagnosis
The diagnosis of ERMS typically involves a combination of physical examination, imaging tests such as MRI or CT scan, and a biopsy of the tumor. The biopsy can confirm the diagnosis and help determine the grade of the cancer, which is an indicator of how aggressive the cancer is likely to be.
Treatment
The treatment for ERMS typically involves a combination of surgery, chemotherapy, and radiation therapy. The specific treatment plan will depend on a variety of factors, including the size and location of the tumor, the grade of the cancer, and the patient's overall health.
Prognosis
The prognosis for ERMS can vary widely depending on a variety of factors, including the size and location of the tumor, the grade of the cancer, the patient's age and overall health, and the response to treatment. In general, the prognosis is better for younger patients and for those with smaller, localized tumors.
